India: Food and Drugs Law

Indian regulators are taking a stricter stance on food and beverage labeling, penalizing companies for misleading "100%" claims even when ingredient lists tell a different story. Two recent enforcement actions demonstrate that prominent product claims will be judged by the message ordinary consumers receive, not by technical compliance with compositional standards or fine-print qualifications.

This comprehensive newsletter examines critical regulatory developments across Legal Metrology, Food Safety, and Agricultural Laws in India during June 2026. From e-commerce country-of-origin filters and fuel dispenser verification reforms to FSSAI's digital compliance initiatives and nano-fertilizer frameworks, the edition covers essential updates impacting manufacturers, exporters, food business operators, and agri-businesses navigating India's evolving regulatory landscape.

India's life sciences and healthcare sector continues to evolve through significant regulatory and policy developments in June 2026. Key changes include pharmacovigilance mandates, prohibition of irrational drug combinations, expanded QR code authentication requirements, cosmetics compliance directions, ART and surrogacy clinic renewal frameworks, safe injection practice mandates, drug price control reforms, and new ambulance service guidelines that reshape pharmaceutical, biotechnology, medical devices, an

The Food Safety and Standards Authority of India has taken a significant step in fortifying the country’s food safety architecture by notifying the Food Safety and Standards (Contaminants, Toxins and Residues)...

In this episode of Podcast Bites by IndiaLaw LLP, host Tanvi Dalvi unpacks the sweeping reforms introduced under the FSSAI 2026 Amendment Regulations, effective 1 April 2026.

India's life sciences and healthcare sector saw significant regulatory shifts in April 2026, including proposed decriminalization of minor violations, new medical device testing fees, and streamlined foreign training requirements for healthcare professionals. Courts also delivered key rulings on pharmaceutical trademark disputes, reinforcing stricter standards for drug name similarity.

The Food Safety and Standards Authority of India (FSSAI) has introduced significant amendments to the Food Safety and Standards (Licensing and Registration of Food Businesses) Regulations through its 2026 Amendment...

In Zydus Lifesciences Ltd. v. E.R. Squibb and Sons LLC & Ors. (FAO(OS) (COMM) 120/2025, CM APPL. 44383/2025, CM APPL. 44386/2025 & CM APPL. 44388/2025), the Division Bench of the Delhi High Court modified the interim order passed by the Single Judge, who had restrained Zydus from manufacturing, using, offering for sale, selling or importing its biosimilar version of the cancer immunotherapy drug Nivolumab in India.

A masala dosa served for ₹100 looks deceptively simple. But behind that single plate lies an entire economy farmers, miners, refiners, manufacturers, logistics operators, warehouses, and restaurants, each link governed by a distinct legal architecture.